Medical Devices UAE

UAE Cardiovascular Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

UAE Cardiovascular Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $291.7 Mn Placeholder estimate
Estimate 2025 $314.5 Mn 0.5% of the global market
Projected 2034 $618.2 Mn 96.6% Adds $303.7 Mn over 9 forecast years
CAGR 2025–2034 7.8% Faster than 26% of 180 Medical Devices markets here
Key players 6 +1
  • UAE is 0.47% of the global market.
  • In Middle East, the largest is Saudi Arabia at $1.23 Bn.
  • Fastest growing: Saudi Arabia at 8.3% a year.
  • UAE ranks 2nd of 4 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$303.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Cardiovascular Devices Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $291.7 Mn — —
2025 (base) $314.5 Mn +$22.8 Mn —
2026 (forecast) $339.0 Mn +$24.5 Mn +7.8%
2027 (forecast) $365.4 Mn +$26.4 Mn +16.2%
2028 (forecast) $393.9 Mn +$28.5 Mn +25.3%
2029 (forecast) $424.7 Mn +$30.7 Mn +35%
2030 (forecast) $457.8 Mn +$33.1 Mn +45.6%
2031 (forecast) $493.5 Mn +$35.7 Mn +56.9%
2032 (forecast) $532.0 Mn +$38.5 Mn +69.2%
2033 (forecast) $573.5 Mn +$41.5 Mn +82.4%
2034 (forecast) $618.2 Mn +$44.7 Mn +96.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

UAE Cardiovascular Devices Market Analysis at a glance
Market size, 2025$314.5 Mn placeholder estimate
Forecast, 2034$618.2 Mn placeholder estimate
Growth (CAGR), 2025–20347.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersMedtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Johnson & Johnson and 1 more (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE Cardiovascular Devices Market Analysis Executive Summary

Cardiovascular devices diagnose, monitor and treat heart and blood vessel disease, from stents and valves to pacemakers.

Key segments of the cardiovascular devices market include product (Stents, Heart Valves and Pacemakers and Defibrillators) and application (Coronary Artery Disease, Arrhythmia and Heart Failure).

Bar chart: UAE Cardiovascular Devices market size, 2024–2034, placeholder estimates. $291.7 Mn in 2024, $314.5 Mn in 2025 and $618.2 Mn in 2034, 7.8% CAGR.
UAE Cardiovascular Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE Cardiovascular Devices Market Dynamics

Market Growth Drivers

An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the cardiovascular devices market.

Opportunity

Smart implants, less invasive techniques and growing access to surgery in emerging economies give the cardiovascular devices market room to grow.

Market Restraints

Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the cardiovascular devices market.

Competitive Landscape for Cardiovascular Devices Market in the UAE

The cardiovascular devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Cardiovascular Devices Market in the UAE

Cardiovascular Devices in the UAE: rules and payment

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cardiovascular devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the UAE.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Cardiovascular Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Cardiovascular Devices in context

The UAE compared

  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 10 countries we cover in Middle East.[1]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 4th highest of the 10 countries we cover in Middle East.[2]
  • People aged 65 and over: 1.8% of people (2025). World: 10.4% of people (2025). 9th highest of the 10 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Cardiovascular Devices market in the UAE?
Placeholder estimate: about $314.5 Mn in 2025, rising to about $618.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Cardiovascular Devices market in the UAE growing?
Placeholder estimate: about 7.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Cardiovascular Devices market report cover?
The report splits the market by product (Stents, Heart Valves, Pacemakers and Defibrillators, Catheters and more), application (Coronary Artery Disease, Arrhythmia, Heart Failure, Structural Heart Disease) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Cardiovascular Devices market?
Key players include Medtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Johnson & Johnson and Biotronik SE & Co. KG.
What is driving the Cardiovascular Devices market?
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the cardiovascular devices market.
Who regulates Cardiovascular Devices in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in UAE

See all

Related on cardiovascular

See the topic